Market Research Logo

Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)

Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Chemotherapy Drugs Market. The report analyzes the Chemotherapy Drugs Market, By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others), By Route of Administration (Oral, Intravenous, Others). The chemotherapy drugs market has been analyzed By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S, Canada, United Kingdom, Germany, China and India) for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to Azoth Analytics research report “Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific and Rest of the World), By Country (U.S, Canada, United Kingdom, Germany, China and India)”, global market is projected to display a robust growth represented by a CAGR of 11.91% during 2018 – 2023.

On the basis of type of chemotherapy drug, plant alkaloids and antitumor antibiotics have been witnessing growth at a noteworthy rate over the past few years backed by effective use of these medications for the treatment of several varieties of cancers such as breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumors, etc. Amongst the regions, North America accounts for the largest regional share in the global chemotherapy drugs market in 2018. However, in the forecast period, the Asia Pacific region is anticipated to advance at the highest pace. Key factors driving the robust growth rate of Asia Pacific region include boosting production of pharmaceuticals, growing incidence of cancer along with government’s focus on medical infrastructural developments.

The report titled “Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, Asia Pacific and Rest of the World), By Country (U.S, Canada, United Kingdom, Germany, China and India)” has covered and analyzed the potential of global chemotherapy drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global chemotherapy drugs market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Chemotherapy Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023

  • Global Chemotherapy Drugs Market – Size, Growth, Forecast
  • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
  • By Route of Administration (Oral, Intravenous, Others)
Regional Markets – North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Regional Chemotherapy Drugs Market – Size, Growth, Forecast
  • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
  • By Route of Administration (Oral, Intravenous, Others)
Country Analysis – U.S, Canada, United Kingdom, Germany, China and India (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Chemotherapy Drugs Market – Size, Growth, Forecast
  • By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others)
  • By Route of Administration (Oral, Intravenous, Others)
Other Report Highlights:
  • Market Dynamics – Drivers and Restraints
  • Market Trends
  • SWOT Analysis
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape
  • Company Analysis – Pfizer, Eli Lilly & Company, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Novartis, Sanofi, Teva Pharmaceutical Industries Limited.


1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Chemotherapy Drugs Market Outlook
Table 1: Common Treatment Modalities for Cancer
Table A: Approach and Limitations of Common Treatment Modalities for Cancer
Table 2: Cancer Treatment Flowchart
Table 3: Chemotherapy Drugs Market Segmentation Flowchart
5. Global Chemotherapy Drugs Market: Growth and Forecast
5.1 By Value (2013-2017)
Table 4: Global Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
5.2 By Value (2018-2023)
Table 5: Global Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
Table 6: Key factors driving of change in the global oncology market
Table 7: Projected global population (In Billions)
Table 8: Population ages 65 and above, By Select Region, 2013-2017 (% of total)
Table 9: Projected global population aged 60 years & above (In Billions)
Table 10: Global Health Expenditure Per Capita, By Select Countries, 2016 (In USD)
Table 11: Global Health Expenditure Per Capita, (2012-2016, USD Trillion)
Table 12: Global Burden of Cancer
Table 13: Prevalence and Epidemiology of Cancer Worldwide
Table 14: 5 Year Survival Rate, Breast and Colorectal Cancer
Table 15: Types of cancer for which clinical trials using chemotherapy drugs treatment are being conducted
Table 16: Global Prevalence of Different Type of Cancer, 2017 (In Thousands)
Table 17: Global Prevalence of Prostate Cancer (2013-2017, Thousands)
Table 18: Oncologists per 1 Million of Population, By Select Country, 2018
Table 19: Availability of New Cancer Drugs Launched in 2012-2016, By Select Country (As of 2017)
Table B: Recent Company Acquisitions and Mergers in Chemotherapy Drugs Market
6. Global Chemotherapy Drugs Market: Segment Analysis
6.1 Global Antimetabolite Chemotherapy Drugs Market, By Value (2013-2023)
Table 20: Global Antimetabolite Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
Table 21: Global Antimetabolite Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
6.2 Global Plant Alkaloid Chemotherapy Drugs Market, By Value (2013-2023)
Table 22: Global Plant Alkaloid Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
Table 23: Global Plant Alkaloid Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
6.3 Global Antitumor Antibiotic Chemotherapy Drugs Market, By Value (2013-2023)
Table 24: Global Alkylating Agent Drugs Market, By Value, 2013-2017 (USD Million)
Table 25: Global Alkylating Agent Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
Table 26: Global Anti-tumor Antibiotic Drugs Market, By Value, 2013-2017 (USD Million)
Table 27: Global Anti-tumor Antibiotic Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
6.4 Other Chemotherapy Drugs Market, By Value (2013-2023)
Table 28: Other Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
Table 29: Other Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
6.5 Global Chemotherapy Drugs Market Size, By Route of Administration: Breakdown (%)
6.5.1 Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)
Table 30: Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)
6.5.2 Global Chemotherapy Drugs Market Size, By Route of Administration, 2023 (%)
Table 31: Global Chemotherapy Drugs Market Size,By Route of Administration, 2023 (%)
6.6 Global Intravenous Chemotherapy Drugs Market, By Value (2013-2023)
Table 32: Global Intravenous Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
Table 33: Global Intravenous Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
6.6 Global Oral Chemotherapy Drugs Market, By Value (2013-2023)
Table 34: Global Oral Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
Table 35: Global Oral Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
6.7 Other Chemotherapy Drugs Market, By Value (2013-2023)
Table 36: Other Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)
Table 37: Other Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)
7. Global Chemotherapy Drugs Market: Regional Analysis
7.1 Global Chemotherapy Drugs Market Size, By Region : Breakdown (%)
7.1.1 Global Chemotherapy Drugs Market Size, By Region, 2017 (%)
Table 38: Global Chemotherapy Drugs Market Size, By Region, 2017 (%)
7.1.2 Global Chemotherapy Drugs Market Size, By Region, 2023 (%)
Table 39: Global Chemotherapy Drugs Market Size, By Region, 2023 (%)
7.2 North America Chemotherapy Drugs Market: Growth and Forecast
7.2.1 By Value (2013-2017)
Table 40: North America Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
7.2.2 By Value (2018-2023)
Table 41: North America Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
7.2.3 By Type of Drug, By Value (2013-2017)
Table 48: North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
7.2.4 By Type of Drug, By Value (2018-2023)
Table 49: North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
7.2.5 By Route of Administration, By Value (2013-2017)
Table 50: North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
7.2.6 By Route of Administration, By Value (2018-2023)
Table 51: North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
7.3 North America Chemotherapy Drugs Market: Country Analysis (U.S and Canada)
7.3.1 U.S Chemotherapy Drugs Market, By Value (2013-2023)
Table 52: U.S. Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
Table 53: Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
Table 54: Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
Table 55: Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)
Table 56: Estimated New Cases of Cancer in the United States, 2014-2018 (In Thousands)
Table 57: Estimated New Cases of Cancer in the United States, By State, 2018
Table 58: Estimated Numbers of US Cancer Survivors (As of January 1, 2016)
Table 59: Estimated Numbers of US Cancer Survivors (As of January 1, 2026F)
Table 60: Factors Influencing Patient Out-of-Pocket Costs for Cancer Medicines
Table 61: United States, Top Players in the chemotherapy drugs market, By Company Share, 2017 (%)
7.3.2 Canada Chemotherapy Drugs Market, By Value (2013-2023)
Table 62: Canada Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
Table 63: Cancer Burden in Canada, 2017
Table 64: Prevalence of Different Type of Cancer in Canada, 2016 & 2017 ( In Hundreds)
Table 65: Cancer Fact Sheet of Canada, 2017
Table 66: Canada, Expenditure on Health as a share of GDP, 2012-2017 (In %)
Table 67: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
Table 68: North America Chemotherapy Drugs Market, Country Share, 2013-2017 (% of Total)
Table 69: North America Chemotherapy Drugs Market, Country Share, 2018F-2023F (% of Total)
7.4 Europe Chemotherapy Drugs Market: Growth and Forecast
7.4.1 By Value (2013-2017)
Table 70: Europe Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
7.4.2 By Value (2018-2023)
Table 71: Europe Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
Table 72: Europe, Cancer Incidence, 2019E-2035F (In Millions)
Table 73: Europe, Cancer Incidence, By Type, 2019E
Table 74: Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Thousands)
Table 75: Europe, Per Capita Health Expenditure, By Select Country, 2017 (USD)
Table 76: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
Table 77: Breakdown of Total Health Expenditure in Europe, 2018 (%)
Table 78: Major Players in Chemotherapy Drugs Market in Europe
7.4.3 By Type of Drug, By Value (2013-2017)
Table 79: Europe Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
7.4.4 By Type of Drug, By Value (2018-2023)
Table 80: Europe Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
7.4.5 By Route of Administration, By Value (2013-2017)
Table 81: Europe Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
7.4.6 By Route of Administration, By Value (2018-2023)
Table 82: Europe Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
7.5 Europe Chemotherapy Drugs Market: Country Analysis (Germany and U.K)
7.5.1 Germany Chemotherapy Drugs Market, By Value (2013-2023)
Table 83: Germany Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
Table C: Germany, Healthcare Related Statistics, 2017
Table 84: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Table 85: Prevalence of Different Type of Cancer in Germany in year 2016 & 2017 ( In Hundreds)
7.5.2 U.K Chemotherapy Drugs Market, By Value (2013-2023)
Table 86: U.K Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
Table 87: Cancer Statistics in the United Kingdom
Table 88: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Table D: Estimated number of people living with cancer, 2020F and 2030F
Table 89: Europe Chemotherapy Drugs Market, Country Share, Historic, 2013-2017(% of Total)
Table 90: Europe Chemotherapy Drugs Market, Country Share, Forecast, 2018-2023 (% of Total)
7.6 APAC Chemotherapy Drugs Market: Growth and Forecast
7.6.1 By Value (2013-2017)
Table 91: APAC Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)
7.6.2 By Value (2018-2023)
Table 92: APAC Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)
Table 93: Estimated number of deaths from prostate cancer in 2012 and 2030
Table 94: World health expenditure as % of GDP
Table 95: Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total)
Table 96: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
Table 97: APAC, GDP, By Select Country, 2017 (In USD Trillion)
Table E: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
7.6.3 By Type of Drug, By Value (2013-2017)
Table 98: APAC Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
7.6.4 By Type of Drug, By Value (2018-2023)
Table 99: APAC Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
7.6.5 By Route of Administration, By Value (2013-2017)
Table 100: APAC Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
7.6.6 By Route of Administration, By Value (2018-2023)
Table 101: APAC Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
7.7 APAC Chemotherapy Drugs Market: Country Analysis (India and China)
7.7.1 India Chemotherapy Drugs Market, By Value (2013-2023)
Table 102: India Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
Table 103: Key factors affecting the Indian Healthcare Industry
Table 104: India, Total Population, 2013-2023F (In Billion)
Table 105: India, Share of Urban Population, 2012-2017 (In %)
Table 106: India, GDP Growth Per Year, 2015-2019 (In %)
Table 107: India, Total deaths due to cancer, 2018
Table 108: Top 5 forms of cancer in men and women in India
Table F: India, Cancer Statistics
7.7.2 China Chemotherapy Drugs Market, By Value (2013-2023)
Table 109: China Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
Table 110: China, GDP Growth Per Year, 2015-2019 (In %)
Table 111: China, Share of Urban Population, 2012-2017 (In %)
Table 112: China, Total Population, 2013-2021F (In Billion)
Table 113: Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)
Table 114: Number of new cases, Males (all ages), 2018 (In %)
Table 115: Number of new cases, Females (all ages), 2018 (In %)
Table 116: China, Cancer Mortality Rate, By Cancer Site, 2018
Table 117: APAC Chemotherapy Drugs Market, Country Share, Historic, 2013-2017 (% of Total)
Table 118: APAC Chemotherapy Drugs Market, Country Share, Forecast, 2018-2023 (% of Total)
7.8 ROW Chemotherapy Drugs Market: Growth and Forecast
7.8.1 By Value (2013-2017)
7.8.2 By Value (2018-2023)
Table 119: ROW Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)
Table 120: Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)
Table 121: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)
Table 122: Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds)
Table 123: Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds)
7.8.3 By Type of Drug, By Value (2013-2017)
Table 124: ROW Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)
7.8.4 By Type of Drug, By Value (2018-2023)
Table 125: ROW Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)
7.8.5 By Route of Administration, By Value (2013-2017)
Table 126: ROW Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)
7.8.6 By Route of Administration, By Value (2018-2023)
Table 127: ROW Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)
Table 128: Drug Discovery and Development, Approximate Timeline
8. Global Chemotherapy Drugs Market Dynamics
8.1 Global Chemotherapy Drugs Market Drivers
8.2 Global Chemotherapy Drugs Market Restraints
9. Global Chemotherapy Drugs Market Trends
10. Porter Five Force Analysis
11. SWOT Analysis
12. Policy and Regulatory Landscape
14. Company Profiles
14.1 Pfizer
Table 129: Pfizer, Revenue, 2013-2017 (In USD Billion)
Table 130: Pfizer, Revenue, By Business Segment, 2017 (In %)
Table 131: Pfizer, Revenue, By National Market, 2015-2017 (In %)
Table 132: Pfizer, Oncology Revenue, 2015-2017 (In USD Million)
14.2 Eli Lilly & Company
Table 133: Eli Lilly & Company, Revenue, 2013-2017 (In USD Billion)
Table 134: Eli Lilly & Company, Revenue, By Business Segment, 2017 (In %)
Table 135: Eli Lilly & Company, Net Sales, By Geographic Region, 2017 (In %)
14.3 CELGENE Corporation
Table 136: CELGENE Corporation, Revenue, 2013-2017 (In USD Million)
Table 137: CELGENE Corporation, Net Sales, By Geographic Region, 2017 (In %)
14.4 Bristol-Myers Squibb
Table 138: Bristol-Myers Squibb, Revenue, 2013-2017 (In USD Million)
Table 139: Bristol-Myers Squibb, Revenue, By Business Segment, 2017 (In %)
Table 140: Bristol-Myers Squibb, Net Sales, By Geographic Region, 2017 (In %)
14.5 Merck & Co., Inc.
Table 141: Merck & Co., Inc., Revenue, 2013-2017 (In USD Million)
Table 142: Merck & Co., Inc., Net Sales, By Geographic Region, 2017 (In %)
14.6 GlaxoSmithKline plc
Table 143: GlaxoSmithKline plc, Revenue, 2013-2017 (In USD Million)
Table 144: GlaxoSmithKline plc, Revenue, By Business Segment, 2017 (In %)
Table 145: GlaxoSmithKline plc, Net Sales, By Geographic Region, 2017 (In %)
14.7 Novartis
Table 146: Novartis, Revenue, 2014-2018 (In USD Million)
Table 147: Novartis, Net Sales, By Business Segment, 2017 (In %)
14.8 Sanofi
Table 148: Sanofi, Revenue, 2013-2017 (In USD Million)
Table 149: Sanofi , Revenue, By Business Segment, 2017 (In %)
Table 150: Sanofi, Net Sales, By Geographic Region, 2017 (In %)
14.9 Teva Pharmaceuticals Industries Limited
Table 151: Teva Pharmaceutical INDUSTRIES LIMITED, Revenue, 2013-2017 (In USD Million)
Table 152: Teva Pharmaceutical INDUSTRIES LIMITED, Revenue, By Business Segment, 2017 (In %)
Table 153: Teva Pharmaceutical INDUSTRIES LIMITED, Net Sales, By Geographic Region, 2017 (In %)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report